Insider Selling: MeiraGTx Holdings plc (NASDAQ:MGTX) CFO Sells $150,960.00 in Stock

MeiraGTx Holdings plc (NASDAQ:MGTX) CFO Richard Giroux sold 24,000 shares of the company’s stock in a transaction dated Tuesday, January 21st. The stock was sold at an average price of $6.29, for a total transaction of $150,960.00. Following the transaction, the chief financial officer now owns 849,947 shares in the company, valued at $5,346,166.63. The trade was a 2.75 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

MeiraGTx Stock Up 0.5 %

Shares of NASDAQ MGTX opened at $6.07 on Friday. MeiraGTx Holdings plc has a 12-month low of $3.85 and a 12-month high of $7.37. The company has a market capitalization of $474.37 million, a PE ratio of -5.02, a price-to-earnings-growth ratio of 0.35 and a beta of 1.26. The company has a debt-to-equity ratio of 0.86, a current ratio of 2.34 and a quick ratio of 2.34. The firm’s 50-day moving average is $6.18 and its two-hundred day moving average is $5.26.

Analyst Ratings Changes

Several brokerages have weighed in on MGTX. Royal Bank of Canada upped their target price on shares of MeiraGTx from $9.00 to $11.00 and gave the stock an “outperform” rating in a research report on Thursday, November 14th. Chardan Capital reaffirmed a “buy” rating and issued a $36.00 price target on shares of MeiraGTx in a report on Monday, November 18th.

Institutional Trading of MeiraGTx

Several institutional investors and hedge funds have recently modified their holdings of MGTX. BNP Paribas Financial Markets lifted its holdings in shares of MeiraGTx by 142.5% in the third quarter. BNP Paribas Financial Markets now owns 9,319 shares of the company’s stock valued at $39,000 after purchasing an additional 5,476 shares in the last quarter. China Universal Asset Management Co. Ltd. lifted its stake in shares of MeiraGTx by 97.0% during the third quarter. China Universal Asset Management Co. Ltd. now owns 14,886 shares of the company’s stock valued at $62,000 after buying an additional 7,330 shares during the period. The Manufacturers Life Insurance Company lifted its stake in shares of MeiraGTx by 19.0% during the second quarter. The Manufacturers Life Insurance Company now owns 17,763 shares of the company’s stock valued at $75,000 after buying an additional 2,839 shares during the period. SG Americas Securities LLC purchased a new position in shares of MeiraGTx during the third quarter valued at approximately $82,000. Finally, Hsbc Holdings PLC lifted its stake in shares of MeiraGTx by 100.9% during the second quarter. Hsbc Holdings PLC now owns 23,954 shares of the company’s stock valued at $102,000 after buying an additional 12,029 shares during the period. Hedge funds and other institutional investors own 67.48% of the company’s stock.

About MeiraGTx

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.